U.S. Markets open in 20 mins
  • S&P Futures

    3,649.75
    -10.75 (-0.29%)
     
  • Dow Futures

    29,673.00
    -131.00 (-0.44%)
     
  • Nasdaq Futures

    12,402.75
    -49.50 (-0.40%)
     
  • Russell 2000 Futures

    1,825.30
    -10.20 (-0.56%)
     
  • Crude Oil

    44.41
    -0.14 (-0.31%)
     
  • Gold

    1,818.30
    -0.60 (-0.03%)
     
  • Silver

    23.84
    -0.25 (-1.04%)
     
  • EUR/USD

    1.2070
    -0.0009 (-0.0724%)
     
  • 10-Yr Bond

    0.9410
    +0.0070 (+0.75%)
     
  • Vix

    21.13
    +0.56 (+2.72%)
     
  • GBP/USD

    1.3303
    -0.0120 (-0.8926%)
     
  • USD/JPY

    104.5730
    +0.2570 (+0.2464%)
     
  • BTC-USD

    19,103.18
    +109.27 (+0.58%)
     
  • CMC Crypto 200

    374.57
    -5.29 (-1.39%)
     
  • FTSE 100

    6,415.83
    +31.10 (+0.49%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

A Look At Benzinga Pro's Most-Searched Tickers For June 28, 2019

Sebastian Brown

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

  1. Cemtrex, Inc. (NASDAQ: CETX) shares were down 23% to $2.91. The stock rose more than 100% on Thursday after the company’s electronic manufacturing services unit won $6 million in new orders over the last quarter.

  2. Atossa Genetics Inc. (NASDAQ: ATOS) shares were down 4.7% to $2.50. The company on Thursday reported its preliminary Phase 2 study achieved its primary endpoint for the topical endoxifen that rapidly reduce breast density.

  3. Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares were down 5.6% to $2.19 after the company on Thursday acquired the global exclusive license of a gene therapy program to address Parkinson's disease from Duke University.

  4. Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares were trading at $13.52. The stock was up 34.5% on Thursday after the company reported FDA approval of its supplemental New Drug Application for DOPTELET for the treatment of chronic immune thrombocytopenia.

  5. Nike, Inc. (NYSE: NKE) shares were trading at $83.19. The company on Thursday reported worse-than-expected Q4 EPS results.

  6. Rite Aid Corp. (NYSE: RAD) shares were down 7.5% to $7.89. Shares rose more than 25% Thursday after the company announced a partnership with Amazon, which plans to use the pharmaceutical retailer as a pickup store for its Amazon customers.

  7. The Howard Hughes Corp. (NYSE: HHC) shares were down 5.8% to $123.54. The stock was up 25% on Thursday after CNBC reported the company hired Centerview Partners to explore alternatives, including a sale.

  8. Micron Technology, Inc. (NASDAQ: MU) shares were up 0.89% to $38.38. On Thursday, Wedbush initiated coverage on the stock with a Neutral rating and announced a $30 price target.

  9. Boeing Co. (NYSE: BA) shares were up 0.4% to $365.51. This week, the International Air Transport Association called for regulators to coordinate on the 737 MAX return to service by aligning MAX pilot training. FAA certification was also a concern.

  10. ATA Inc. (NASDAQ: ATAI) shares were up 11.5% to $2.89 after the company announced the terms of its agreement to acquire ACG, a leading China-based service provider of overseas art education.

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.